Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Short-term Investments (2016 - 2020)

Sensus Healthcare has reported Short-term Investments over the past 5 years, most recently at $459295.0 for Q2 2020.

  • For Q2 2020, Short-term Investments fell 91.48% year-over-year to $459295.0; the TTM value through Jun 2020 reached $459295.0, down 91.48%, while the annual FY2019 figure was $7.4 million, 155.5% up from the prior year.
  • Short-term Investments for Q2 2020 was $459295.0 at Sensus Healthcare, down from $3.7 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $8.0 million in Q3 2019 and troughed at $459295.0 in Q2 2020.
  • A 5-year average of $4.5 million and a median of $4.7 million in 2019 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: skyrocketed 161.82% in 2018 and later plummeted 91.48% in 2020.
  • Year by year, Short-term Investments stood at $6.5 million in 2016, then plummeted by 82.91% to $1.1 million in 2017, then skyrocketed by 161.82% to $2.9 million in 2018, then soared by 155.5% to $7.4 million in 2019, then tumbled by 93.78% to $459295.0 in 2020.
  • Business Quant data shows Short-term Investments for SRTS at $459295.0 in Q2 2020, $3.7 million in Q1 2020, and $7.4 million in Q4 2019.